Welcome to LookChem.com Sign In|Join Free

CAS

  • or
indolmycin is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

21193-77-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 21193-77-1 Structure
  • Basic information

    1. Product Name: indolmycin
    2. Synonyms: indolmycin
    3. CAS NO:21193-77-1
    4. Molecular Formula: C14H15N3O2
    5. Molecular Weight: 257.2878
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 21193-77-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 420.8°C at 760 mmHg
    3. Flash Point: 208.3°C
    4. Appearance: /
    5. Density: 1.36g/cm3
    6. Vapor Pressure: 2.75E-07mmHg at 25°C
    7. Refractive Index: 1.669
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: indolmycin(CAS DataBase Reference)
    11. NIST Chemistry Reference: indolmycin(21193-77-1)
    12. EPA Substance Registry System: indolmycin(21193-77-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 21193-77-1(Hazardous Substances Data)

21193-77-1 Usage

Uses

Indolmycin is an antibiotic that inhibits bacterial tryptophanyl-tRNA synthetase.

Check Digit Verification of cas no

The CAS Registry Mumber 21193-77-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,1,9 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 21193-77:
(7*2)+(6*1)+(5*1)+(4*9)+(3*3)+(2*7)+(1*7)=91
91 % 10 = 1
So 21193-77-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H15N3O2/c1-8(12-13(18)17-14(15-2)19-12)10-7-16-11-6-4-3-5-9(10)11/h3-8,12,16H,1-2H3,(H,15,17,18)

21193-77-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(1-indol-3-yl-ethyl)-2-methylamino-oxazol-4-one

1.2 Other means of identification

Product number -
Other names 5-[1-(1H-Indol-3-yl)-ethyl]-2-[(Z)-methylimino]-oxazolidin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21193-77-1 SDS

21193-77-1Downstream Products

21193-77-1Relevant articles and documents

Total synthesis of (±) indolmycin

Shue, Youe-Kong

, p. 6447 - 6448 (2007/10/03)

A practical and short synthesis of a novel antibiotic, (±) indolmycin, has been accomplished. The overall process requires only 4 chemical steps by starting from gramine derivative 3 and oxazolinone 2.

Structure-activity dependency of new bacterial tryptophanyl tRNA synthetase inhibitors

Witty, David R.,Walker, Graham,Bateson, John H.,O'Hanlon, Peter J.,Cassels, Robert

, p. 1375 - 1380 (2007/10/03)

Analogues of the aminoacyl tRNA synthetase inhibitor, indolmycin, have been synthesised in which the side chain methyl group is replaced by a wide range of substituents. Their antibacterial and enzyme inhibitory potency is related to steric properties and

New Total Synthesis of (+/-)-Indolmycin

Dirlam, John P.,Clark, David A.,Hecker, Scott J.

, p. 4920 - 4924 (2007/10/02)

A convergent total synthesis of the antibiotic (+/-)-indolmycin (1) is presented.N-Carbobenzoxy-3-(1-chloroethyl)indole (12) is prepared in three steps from indole-3-carboxaldehyde (9).Alkylation of the lithium anion of 2-(dimethylamino)-4(5H)-oxazolone (4) with chloride (12) provides a mixture of the (+/-)-2-dimethylamino derivative of indolmycin (13) and its diastereomer (14) in a ratio of 2.2:1.Amine exchange is effected by treatment of 13 with methylamine, affording (+/-)-1 in five steps from commercially available 9.Efforts to extend this technology toward an asymmetric synthesis of (-)-1 are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21193-77-1